CMH :: Clinical and Molecular Hepatology

Clinical and Molecular Hepatology Search

> Browse Articles > Search

Serum matrix metalloproteinase-1 level represents disease activity as opposed to fibrosis in patients with histologically proven nonalcoholic steatohepatitis

Wataru Ando, Hiroaki Yokomori, Nobuhiro Tsutsui, Eigoro Yamanouchi, Yutaka Suzuki, Masaya Oda, Yutaka Inagaki, Katsuya Otori, Isao Okazaki

Clin Mol Hepatol.2018;24(1):61-76. Published online November 20, 2017
DOI: https://doi.org/10.3350/cmh.2017.0030

Role of liver transplantation in severe alcoholic hepatitis

Ravi Daswani, Ashish Kumar, Praveen Sharma, Vikas Singla, Naresh Bansal, Anil Arora

Clin Mol Hepatol.2018;24(1):43-50. Published online January 10, 2018
DOI: https://doi.org/10.3350/cmh.2017.0027

Cited By 1

Prevention and management of gastroesophageal varices

Yeon Seok Seo

Clin Mol Hepatol.2018;24(1):20-42. Published online December 18, 2017
DOI: https://doi.org/10.3350/cmh.2017.0064

Histopathological evaluation of liver fibrosis and cirrhosis regression

Regina C. Lo, Haeryoung Kim

Clin Mol Hepatol.2017;23(4):302-307. Published online December 20, 2017
DOI: https://doi.org/10.3350/cmh.2017.0078

Cited By 1

Life-sustaining treatment and palliative care in patients with liver cirrhosis - legal, ethical, and practical issues

Dong Joon Kim, Moon Seok Choi

Clin Mol Hepatol.2017;23(2):115-122. Published online May 2, 2017
DOI: https://doi.org/10.3350/cmh.2017.0018

Cited By 3

Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis

Gaeun Kim, Moon Young Kim, Soon Koo Baik

Clin Mol Hepatol.2017;23(1):34-41. Published online March 7, 2017
DOI: https://doi.org/10.3350/cmh.2016.0059

Cited By 13

Transient elastography can be integrated into routine clinical practice for the evaluation of portal hypertension?

Beom Kyung Kim

Clin Mol Hepatol.2017;23(1):27-30. Published online March 24, 2017
DOI: https://doi.org/10.3350/cmh.2017.0101

Cited By 1

Anticoagulation in cirrhosis: a new paradigm?

Filippo Leonardi, Nicola De Maria, Erica Villa

Clin Mol Hepatol.2017;23(1):13-21. Published online March 14, 2017
DOI: https://doi.org/10.3350/cmh.2016.0110

Cited By 1

Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban

Hyeyoung Yang, Seo Ree Kim, Myeong Jun Song

Clin Mol Hepatol.2016;22(4):499-502. Published online November 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0016

Cited By 5

Cyanoacrylate injection versus band ligation for bleeding from cardiac varices along the lesser curvature of the stomach

Sang Jung Park, Yong Kwon Kim, Yeon Seok Seo, Seung Woon Park, Han Ah Lee, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jae Young Jang, Jong Eun Yeon, Kwan Soo Byun

Clin Mol Hepatol.2016;22(4):487-494. Published online December 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0050

Cited By 2

Emergency endoscopic variceal ligation in cirrhotic patients with blood clots in the stomach but no active bleeding or stigmata increases the risk of rebleeding

Su Jin Kim, Cheol Woong Choi, Dae Hwan Kang, Hyung Wook Kim, Su Bum Park, Young Mi Hong, Ki Tae Yoon, Mong Cho, Hyung Seok Nam, SM Bakhtiar UI Islam

Clin Mol Hepatol.2016;22(4):466-476. Published online December 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0063

Cited By 1

Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy

Soon Jae Lee, Yoo-Kyung Cho, Soo-Young Na, Eun Kwang Choi, Sun Jin Boo, Seung Uk Jeong, Hyung Joo Song, Heung Up Kim, Bong Soo Kim, Byung-Cheol Song

Clin Mol Hepatol.2016;22(3):390-395. Published online August 30, 2016
DOI: https://doi.org/10.3350/cmh.2015.0050

Decreased C-reactive protein induces abnormal vascular structure in a rat model of liver dysfunction induced by bile duct ligation

Ji Hye Jun, Jong Ho Choi, Si Hyun Bae, Seh Hoon Oh, Gi Jin Kim

Clin Mol Hepatol.2016;22(3):372-381. Published online September 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0032

Cited By 2

Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment

Hong Joo Kim, Soo Kyung Park, Hyo Joon Yang, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyu Yong Choi

Clin Mol Hepatol.2016;22(3):350-358. Published online September 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0019

Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection

Hee Chul Nam, Hae Lim Lee, Hyun Yang, Myeong Jun Song

Clin Mol Hepatol.2016;22(2):259-266. Published online June 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0020

Cited By 3

Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis

Hye Young Jwa, Yoo-Kyung Cho, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong, Bong Soo Kim, Byoung-Wook Lee, Byung-Cheol Song

Clin Mol Hepatol.2016;22(1):183-187. Published online March 28, 2016
DOI: https://doi.org/10.3350/cmh.2016.22.1.183

Cited By 1

Magnetization-tagged MRI is a simple method for predicting liver fibrosis

Kyung-Eun Kim, Mi-Suk Park, Sohae Chung, Chansik An, Leon Axel, Rakhmonova Gulbahor Ergashovna

Clin Mol Hepatol.2016;22(1):140-145. Published online March 28, 2016
DOI: https://doi.org/10.3350/cmh.2016.22.1.140

Acute-on-chronic liver failure: a new syndrome in cirrhosis

Richard Moreau

Clin Mol Hepatol.2016;22(1):1-6. Published online March 28, 2016
DOI: https://doi.org/10.3350/cmh.2016.22.1.1

Cited By 10

Erectile dysfunction in patients with liver disease related to chronic hepatitis B

Min Kim, Seul Young Kim, Woo Sun Rou, Se Woong Hwang, Byung Seok Lee

Clin Mol Hepatol.2015;21(4):352-357. Published online December 24, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.4.352

Cited By 2

What we know about paracentesis induced circulatory dysfunction?

Jeong Han Kim

Clin Mol Hepatol.2015;21(4):349-351. Published online December 24, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.4.349

Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes

Yoonsang Park, Yuri Cho, Eun Ju Cho, Yoon Jun Kim

Clin Mol Hepatol.2015;21(2):150-157. Published online June 26, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.2.150

Cited By 3

Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis

Yoon Ok Jang, Baek Gyu Jun, Soon Koo Baik, Moon Young Kim, Sang Ok Kwon

Clin Mol Hepatol.2015;21(2):141-149. Published online June 26, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.2.141

Cited By 17

Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis

Jung Wha Chung, Gi Hyun Kim, Jong Ho Lee, Kyeong Sam Ok, Eun Sun Jang, Sook-Hyang Jeong, Jin-Wook Kim

Clin Mol Hepatol.2014;20(4):384-391. Published online December 24, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.4.384

Cited By 15

Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension

Jae Hyun Kim, Jung Min Kim, Youn Zoo Cho, Ji Hoon Na, Hyun Sik Kim, Hyoun A Kim, Hye Won Kang, Soon Koo Baik, Sang Ok Kwon, Seung Hwan Cha, Young Ju Kim, Moon Young Kim

Clin Mol Hepatol.2014;20(4):376-383. Published online December 24, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.4.376

Cited By 10

Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B

Hyo Jung Cho, Soon Sun Kim, Seun Joo Ahn, Joo Han Park, Dong Joon Kim, Young Bae Kim, Sung Won Cho, Jae Youn Cheong

Clin Mol Hepatol.2014;20(4):347-354. Published online December 24, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.4.347

Cited By 7

Chemotherapy induced liver abnormalities: an imaging perspective

Ankush Sharma, Roozbeh Houshyar, Priya Bhosale, Joon-Il Choi, Rajesh Gulati, Chandana Lall

Clin Mol Hepatol.2014;20(3):317-326. Published online September 25, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.3.317

Cited By 3

Prediction of fibrosis progression in chronic viral hepatitis

Grace Lai-Hung Wong

Clin Mol Hepatol.2014;20(3):228-236. Published online September 25, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.3.228

Cited By 14

Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal

Yun Jung Choi, Jeong Han Kim, Ja Kyung Koo, Cho I Lee, Ji Young Lee, Jae Hoon Yang, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee

Clin Mol Hepatol.2014;20(2):185-191. Published online June 30, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.2.185

Cited By 5

The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites

Jun Jae Kim, Jeong Han Kim, Ja Kyung Koo, Yun Jung Choi, Soon Young Ko, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol.2014;20(1):47-55. Published online March 26, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.1.47

Cited By 1

Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data

Hyung Ki Kim, Yoon Jun Kim, Woo Jin Chung, Soon Sun Kim, Jae Jun Shim, Moon Seok Choi, Do Young Kim, Dae Won Jun, Soon Ho Um, Sung Jae Park, Hyun Young Woo, Young Kul Jung, Soon Koo Baik, Moon Young Kim, Soo Young Park, Jae Myeong Lee, Young Seok Kim

Clin Mol Hepatol.2014;20(1):18-27. Published online March 26, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.1.18

Cited By 8

1 | 2 | 3 | 4 | 5 |

The Korean Association for the Study of the Liver